"But importantly, later time-point imaging presents significant benefits for doing what cancer diagnostics need to do, and that is finding cancer."
GOLD!
Ann: Last patient assessment completed for SARTATE trial, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$4.21 |
Change
0.100(2.43%) |
Mkt cap ! $1.361B | |||
| Open | High | Low | Value | Volume |
| $4.46 | $4.62 | $4.20 | $29.97M | 6.888M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 2004 | $4.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.25 | 1749 | 1 |
View Market Depth
| Last trade - 16.10pm 28/07/2025 (20 minute delay) ? |
| CU6 (ASX) Chart |